Clinical Trial Update: An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating the efficacy of umeclidinium/vilanterol (Anoro Ellipta) in combination with tiotropium/olodaterol (Stiolto) in patients with ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Anoro Ellipta (umeclidinium bromide; vilanterol trifenatate)
• Stiolto Respimat (tiotropium + olodaterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2018-07-02